Journal of Cellular and Molecular Medicine
Journal of Cellular and Molecular Medicine is a bimonthly peer-reviewed journal published by Wiley-Blackwell, covering cellular and molecular medicine. Founded in 1997, it bridges physiology, cellular medicine, molecular biology, and molecular therapeutics, with a 2025 impact factor of 4.7, indexed in SCIE.《细胞与分子医学杂志》（Journal of Cellular and Molecular Medicine, 简称 JCMM）是由 Wiley-Blackwell 出版的双月刊同行评审期刊，涵盖细胞与分子医学。该刊创刊于 1997 年，衔接生理学、细胞医学、分子生物学与分子治疗学，2025 年影响因子为 4.7，被 SCIE 收录。
Scope
The journal's stated aim is to publish original research and concepts in all fields of cellular and molecular medicine, with its official scope covering:刊物官方宗旨为发表细胞与分子医学所有领域的原创研究与概念，官方声明的征稿范围包括：
- Cellular mechanisms of disease: original research on the cellular and molecular mechanisms underlying human diseases, including signaling pathways and gene regulation.疾病细胞机制： 关于人类疾病细胞与分子机制的原创研究，包括信号通路与基因调控。
- Molecular therapeutics: studies on the development and application of molecular therapies, including gene therapy, targeted therapy, and regenerative medicine.分子治疗学： 关于分子治疗开发与应用的研究，包括基因治疗、靶向治疗与再生医学。
- Translational medicine: research that bridges basic biomedical science with clinical applications, from bench to bedside.转化医学： 衔接基础生物医学科学与临床应用的研究，从实验台到病床。
- Stem cells and development: studies on stem cell biology, tissue engineering, and developmental processes relevant to human health and disease.干细胞与发育： 关于与人类健康和疾病相关的干细胞生物学、组织工程与发育过程的研究。
- Article types: the journal publishes original research articles, reviews, and short communications in cellular and molecular medicine.栏目设置： 该刊发表细胞与分子医学领域的原创研究论文、综述与短讯。
History
- Founding: the journal was established in 1997 to provide an interdisciplinary forum for cellular and molecular medicine research.创刊： 该刊于 1997 年创刊，为细胞与分子医学研究提供跨学科论坛。
- FCMM publication: JCMM is co-owned by the Foundation for Cellular and Molecular Medicine and published by John Wiley & Sons.FCMM 出版： JCMM 由细胞与分子医学基金会与 John Wiley & Sons 共同所有并出版。
- Interdisciplinary focus: throughout its history, the journal has emphasized the interface between basic cellular and molecular biology and clinical medicine.跨学科聚焦： 在其发展历程中，该刊始终强调基础细胞与分子生物学和临床医学之间的交叉。
- Publication frequency: the journal publishes bimonthly, ensuring regular dissemination of important advances in cellular and molecular medicine.出版频率： 该刊每两个月出版一期，确保细胞与分子医学重要进展的定期传播。
Editors
The journal is led by an editor-in-chief supported by associate editors and an editorial board:该刊由主编领导，副主编与编委会协助工作：
- Editor-in-chief: Stefan N. Constantinescu of the Université Catholique de Louvain, de Duve Institute, Brussels, Belgium, serves as the editor-in-chief.主编： 比利时布鲁塞尔天主教卢万大学德迪夫研究所的斯特凡·N·康斯坦丁内斯库（Stefan N. Constantinescu）担任主编。
- Associate editors: the editor-in-chief is supported by associate editors with expertise across major areas of cellular and molecular medicine.副主编： 主编由具有细胞与分子医学主要领域专长的副主编协助。
- Editorial board: the journal has a large international editorial board comprising biomedical researchers and clinicians from leading institutions worldwide.编委会： 该刊拥有大型国际编委会，成员为来自全球顶尖机构的生物医学研究者与临床医生。
- Open access option: authors can choose to publish open access in this journal, making their articles freely available to readers upon publication in exchange for an article processing charge.开放获取选项： 作者可选择在该刊发表开放获取文章，使论文发表后即向读者免费开放，并支付文章处理费。